{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T18:06:19Z","timestamp":1726423579533},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.transproceed.2004.10.088","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T12:33:49Z","timestamp":1107261229000},"page":"3190-3193","source":"Crossref","is-referenced-by-count":6,"title":["Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation?"],"prefix":"10.1016","volume":"36","author":[{"given":"M.","family":"Mohyeddin Bonab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Alimoghaddam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vatandoust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Forouzia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Jahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ghavamzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2004.10.088_bib1","first-page":"676","article-title":"Allogeneic marrow transplantation for thalassemia","volume":"12","author":"Lucarelli","year":"1984","journal-title":"Exp Hematol"},{"year":"2000","series-title":"Kuby immunology","author":"Goldsby","key":"10.1016\/j.transproceed.2004.10.088_bib2"},{"key":"10.1016\/j.transproceed.2004.10.088_bib3","first-page":"663","article-title":"Impact of donor and recipient characteristics on the development of acute and chronic graft-versus-host disease following pediatric bone marrow transplantation","volume":"15","author":"Eisner","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2004.10.088_bib4","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/bbmt.2002.v8.abbmt080674","article-title":"Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Remberger","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2004.10.088_bib5","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/bbmt.2001.v7.pm11760150","article-title":"Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion","volume":"7","author":"Keever-Taylor","year":"2001","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transproceed.2004.10.088_bib6","first-page":"747","article-title":"Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients","volume":"16","author":"Hagglund","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2004.10.088_bib7","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood.V80.7.1838.1838","article-title":"Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate","volume":"80","author":"Nash","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2004.10.088_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-9343(97)89488-0","article-title":"Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology","volume":"100","author":"Van Besien","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.transproceed.2004.10.088_bib9","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.V94.4.1465","article-title":"Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation","volume":"94","author":"Przepiorka","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2004.10.088_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF02982797","article-title":"The association of HLA antigen and GVHD in allogeneic hemopoietic stem cell transplantation with histocompatible sibling donor: a single-center experience in Korea","volume":"76","author":"Kim","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.transproceed.2004.10.088_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2141.2001.02897.x","article-title":"HLA-A3 increases and HLA-DR1 decreases the risk of acute graft-versus-host disease after HLA-matched sibling bone marrow transplantation for chronic myelogenous leukaemia","volume":"114","author":"Clark","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2004.10.088_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1056\/NEJM199002223220805","article-title":"T-lymphocyte-antigen interaction in transplant rejection","volume":"322","author":"Krensky","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.10.088_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJM199002153220701","article-title":"Bone marrow transplantation in patients with thalassemia","volume":"322","author":"Lucarelli","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.10.088_bib14","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJM198704233161703","article-title":"Marrow transplantation in patients with advanced thalassemia","volume":"316","author":"Lucarelli","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2004.10.088_bib15","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transproceed.2004.10.088_bib16","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/00007890-199106000-00010","article-title":"Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation","volume":"51","author":"Weisdorf","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.10.088_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1046\/j.1365-2141.2002.03924.x","article-title":"An association between human leucocyte antigen alleles and acute and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation","volume":"119","author":"Remberger","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2004.10.088_bib18","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1182\/blood-2004-02-0508","article-title":"Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation","volume":"104","author":"Adams","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2004.10.088_bib19","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(83)90737-7","article-title":"Association between HLA-B antigens and acute graft-versus-host disease","volume":"2","author":"Storb","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2004.10.088_bib20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood.V63.6.1265.1265","article-title":"Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow","volume":"63","author":"Bross","year":"1984","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2004.10.088_bib21","first-page":"16","article-title":"HLA and risk of acute graft versus host disease in allogenic bone marrow transplantation from an HLA-identical sibling","volume":"5","author":"Ghavamzadeh","year":"2002","journal-title":"Arch Irn Med"},{"key":"10.1016\/j.transproceed.2004.10.088_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-2141.1987.tb06160.x","article-title":"Risk factors for acute graft-versus-host disease","volume":"67","author":"Gale","year":"1987","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transproceed.2004.10.088_bib23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/00007890-199703270-00011","article-title":"Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors","volume":"63","author":"Gaziev","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2004.10.088_bib24","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1182\/blood.V94.4.1465","article-title":"Risk factors for acute graftiversus-host disease after allogeneic blood stem cell transplantation","volume":"94","author":"Przepiorka","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2004.10.088_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1083-8791(98)50001-8","article-title":"HLAs and risk of acute graft-vs-host disease after marrow transplantation from an HLA-identical sibling","volume":"4","author":"Martin","year":"1998","journal-title":"Biology of Blood and Marrow Transplantation"},{"key":"10.1016\/j.transproceed.2004.10.088_bib26","first-page":"359","article-title":"HLA class-I specific inhibitory receptors","volume":"16","author":"Moretta","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.transproceed.2004.10.088_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0198-8859(02)00373-7","article-title":"Relevance of KIR gene polymorphisms in bone marrow transplantation outcome","volume":"63","author":"Gagne","year":"2002","journal-title":"Huma Immunol"},{"key":"10.1016\/j.transproceed.2004.10.088_bib28","doi-asserted-by":"crossref","first-page":"3825","DOI":"10.1182\/blood-2002-04-1197","article-title":"Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants","volume":"100","author":"Davies","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.transproceed.2004.10.088_bib29","first-page":"29","article-title":"Natural killer cells, HLA class I molecules, and marrow transplantation","volume":"3","author":"Valiante","year":"1997","journal-title":"Biology of Blood and Marrow Transplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134504012874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134504012874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,5]],"date-time":"2020-04-05T14:49:12Z","timestamp":1586098152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134504012874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0041134504012874"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2004.10.088","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}